Found 45 articles for: "Hair"
Moringa-Derived Formulations for Hair Growth, Hair Preservation, and Hair Loss: A Systematic Review
July 2026 | Volume 25 | Issue 7 | Original Article | 644 | Copyright © July 2026
Background: Hair plays a central role in personal identity, societal interactions, and cultural expression. As a result, hair growth, preservation, and loss are common dermatolog...
Read MoreAlopecia Areata in Children and the Emerging Role of JAK Inhibitors
July 2026 | Volume 25 | Issue 7 | Features | e61 | Copyright © July 2026
Rethinking the Link Between Hair Relaxers and Uterine Cancer
July 2026 | Volume 25 | Issue 7 | Editorials | e68 | Copyright © July 2026
Hidden Harms of Hair Relaxers: A Call to Action
July 2026 | Volume 25 | Issue 7 | Editorials | 672 | Copyright © July 2026
Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
March 2026 | Volume 25 | Issue 3 | Original Article | 204 | Copyright © March 2026
Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss on the scalp and body, leading to a reduced quality of life and psychosocial burden for patients. The only US ...
Read MoreUpdates on Therapeutic Approaches for Management of Androgenetic Alopecia: A Review
March 2026 | Volume 25 | Issue 3 | Original Article | 240 | Copyright © March 2026
Androgenetic alopecia (AGA) is a common, progressive form of nonscarring hair loss, affecting both men and women. Its pathogenesis is largely driven by androgenic factors, including elevated dihy...
Read MorePerspectives and Practice Patterns of Dermatologists Using Laser Hair Removal for Hidradenitis Suppurativa
December 2025 | Volume 24 | Issue 12 | Editorials | e71 | Copyright © December 2025
Caffeine Supplementation and Hair: A Systematic Review
November 2025 | Volume 24 | Issue 11 | Original Article | 1070 | Copyright © November 2025
Background: While caffeine has been proposed to stimulate hair growth, its safety and efficacy remain unclear. This systematic review evaluates the effects of caffeine interventi...
Read MoreAn Exosome Regenerative Complex Plus Microneedling Promotes Hair Growth in Subjects With Self-Perceived Thinning Hair
October 2025 | Volume 24 | Issue 10 | Original Article | 988 | Copyright © October 2025
Thinning hair affects the quality of life of affected men and women but has limited treatment options. A novel technology refines exosomes from stem cells to create a concentrated complex that is...
Read MoreMicroneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia
October 2025 | Volume 24 | Issue 10 | Editorials | e59 | Copyright © October 2025
Hair Transplantation in Women
September 2025 | Volume 24 | Issue 9 | Original Article | 851 | Copyright © September 2025
Background: Hair transplantation is a widely used treatment for androgenetic alopecia (AGA) and other hair loss conditions, with increasing demand from women in recent years.Read MoreHalobetasol Propionate/Tazarotene Lotion for Scalp Psoriasis: Efficacy in Itch Reduction, Disease Clearance, and Hair Appearance
August 2025 | Volume 24 | Issue 8 | Original Article | 752 | Copyright © August 2025
Scalp involvement in plaque psoriasis is accompanied by itching and scaling that reduce quality of life and exacerbate psoriatic-associated hair loss. Challenges for the topical treatment of scal...
Read MorePerceptions and Knowledge of Dermatologic Side Effects of Anti-Cancer Therapies: A Pilot Survey
August 2025 | Volume 24 | Issue 8 | Editorials | e57 | Copyright © August 2025
Commonly Prescribed Hair Loss Treatments Are Rarely Designated as Dermatologic Agents by Insurance Companies
August 2025 | Volume 24 | Issue 8 | Editorials | e53 | Copyright © August 2025
Alopecia Areata in Skin of Color: Trichoscopic Analysis in Black/African American Patients
July 2025 | Volume 24 | Issue 7 | Features | 708 | Copyright © July 2025
Importance: Alopecia areata (AA) has a higher prevalence in populations with skin of color, yet the trichoscopic features in this population remain underexplored.Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions
July 2025 | Volume 24 | Issue 7 | Original Article | 659 | Copyright © July 2025
Female hair loss affects over 50% of postmenopausal women, with up to 40% of healthy women experiencing frontal/parietal hair loss, often beginning around reproductive age. Androgenetic alopecia ...
Read MoreSingle-Center, Open-Label Study Study to Evaluate Improvement of Hair Appearance With Novel Hair Growth Serum
April 2025 | Volume 24 | Issue 4 | Original Article | 394 | Copyright © April 2025
Background: REVIVV® is a topical hair growth serum with a proprietary formula of botanicals that addresses multiple factors involved in hair loss pathophysiol...
Read MoreArtificial Intelligence-Based Personalization of Treatment Regimen for Hair Loss: A 6-Month Clinical Trial
March 2025 | Volume 24 | Issue 3 | Original Article | 233 | Copyright © March 2025
Hair loss affects up to 50% of women and 80% of men. The high costs and wait times for professional consultations lead many to seek one-size-fits-all solutions that are frequently ineffective. Th...
Read MoreAlopecia as an Adverse Event of Immune Checkpoint Inhibitor Therapies: Clinical Evidence and Outcomes
March 2025 | Volume 24 | Issue 3 | Original Article | 255 | Copyright © March 2025
Immunotherapy utilizing immune checkpoint inhibitors (ICIs) such as PD-1, PD-L1, and CTLA-4 inhibitors has revolutionized cancer therapy by enhancing T cell recognition and attack against cancer ...
Read MoreDifferentiating and Managing Cutaneous Lupus Erythematosus-Associated Alopecia and Patchy Alopecia Areata: Therapeutic Insights From Case Studies
March 2025 | Volume 24 | Issue 3 | Case Reports | 324 | Copyright © March 2025
Cutaneous lupus erythematosus (CLE) is an autoimmune disease with diverse clinical manifestations, including patchy hair loss© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
